Your browser doesn't support javascript.
loading
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma.
Allen, Bryan G; Bodeker, Kellie L; Smith, Mark C; Monga, Varun; Sandhu, Sonia; Hohl, Raymond; Carlisle, Thomas; Brown, Heather; Hollenbeck, Nancy; Vollstedt, Sandy; Greenlee, Jeremy D; Howard, Matthew A; Mapuskar, Kranti A; Seyedin, Steven N; Caster, Joseph M; Jones, Karra A; Cullen, Joseph J; Berg, Daniel; Wagner, Brett A; Buettner, Garry R; TenNapel, Mindi J; Smith, Brian J; Spitz, Douglas R; Buatti, John M.
Affiliation
  • Allen BG; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Bodeker KL; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Smith MC; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Monga V; Division of Hematology and Oncology, Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Sandhu S; Division of Hematology and Oncology, Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Hohl R; Penn State Cancer Institute, Hershey, Pennsylvania.
  • Carlisle T; Division of Hematology and Oncology, Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Brown H; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Hollenbeck N; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Vollstedt S; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Greenlee JD; Department of Neurosurgery, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Howard MA; Department of Neurosurgery, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Mapuskar KA; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Seyedin SN; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Caster JM; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Jones KA; Department of Pathology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Cullen JJ; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Berg D; Division of Hematology and Oncology, Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Wagner BA; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Buettner GR; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • TenNapel MJ; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Smith BJ; Department of Biostatistics, The University of Iowa, Iowa City, Iowa.
  • Spitz DR; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa.
  • Buatti JM; Department of Radiation Oncology, University of Iowa Hospitals & Clinics, Iowa City, Iowa. john-buatti@uiowa.edu.
Clin Cancer Res ; 25(22): 6590-6597, 2019 11 15.
Article in En | MEDLINE | ID: mdl-31427282

Full text: 1 Database: MEDLINE Main subject: Radiotherapy / Glioblastoma / Antineoplastic Agents, Alkylating / Temozolomide Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Radiotherapy / Glioblastoma / Antineoplastic Agents, Alkylating / Temozolomide Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2019 Type: Article